Physician profile
Katelyn E Kenny
NPI 1962027813
$498.73
in general payments reported to CMS, 2019-2025
11 companies · $25.70 in 2025
The $25.70 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $309 · 2025: $25.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $179.70 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $64.39 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $62.85 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.31 | 2021-2022 | |
| Hologic Sales and Service, LLC | $25.70 | 2025 | Thinprep 2000 Processor, Aptima |
| Pfizer INC. | $25.05 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $21.08 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.71 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.05 | 2022 | |
| Dynavax Technologies Corporation | $15.95 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Kenny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.